Physiologic Indicators for Prognosis in Abdominal Sepsis Study (PIPAS)

September 17, 2018 updated by: Massimo Sartelli, World Society of Emergency Surgery

Physiologic Indicators for Prognosis in Abdominal Sepsis (PIPAS) Study

Early detection and timely therapeutic intervention can improve the prognosis of patients with sepsis. However, early diagnosis of sepsis can be difficult; because determining which patients presenting with signs of infection during an initial evaluation, do currently have, or will later develop a more serious illness is not easy.

Physiological deterioration often precedes clinical deterioration as patients develop critical illness. In this study, the investigators aim to evaluate vital signs in a global cohort of patients with acute secondary peritonitis, determining which parameters are statistically significant to predict in-hospital mortality and ICU admission.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The study will be a worldwide multicenter observational study. The study will include patients admitted in the surgical department with acute peritonitis during a four-month study period (February 1, 2018 - May 31, 2018).

The study will not attempt to change or modify the clinical practice of the participating physicians: neither informed consent or formal approval by local Ethics Committee will be required because of the purely observational nature of the study.

The study will be monitored by the principal investigator, which will investigate and verify missing or unclear data submitted to a central database.

The study protocol has been approved by the board of the WSES and the study will be conducted under its supervision. The board of the WSES grants the proper ethical conduct of the study.

The data collection will be anonymous, as well as the name of the patients or hospital will be not collected in the website. Every hospital will continue following their ethical standards and local rules. The list of the submitted cases will not be recognized by investigators and linked to the submitting hospital. Individual researchers will take personal responsibility of data collection of this study.

In each center, the coordinator will collect and fill the data in an online case report system. These data included the following:

  • Patient and disease characteristics
  • Diagnostic profiles
  • Treatment profiles
  • Post-operative course

Study Type

Observational

Enrollment (Actual)

4000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bologna, Italy, 40139
        • WSES

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All patients admitted to surgical departments with acute secondary peritonitis

Description

Inclusion Criteria:

- Clinical diagnosis of acute (secondary) localized or diffuse peritonitis.

Exclusion Criteria:

- Clinical diagnosis of acute pancreatitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory rate predicting mortality in patients with acute secondary peritonitis at admission
Time Frame: 24 weeks
Respiratory rate (breaths/min);
24 weeks
Blood oxygen saturation level predicting mortality in patients with acute secondary peritonitis at admission
Time Frame: 24 weeks
Blood oxygen saturation level (SpO2) (%) in air
24 weeks
Core temperature predicting mortality in patients with acute secondary peritonitis at admission
Time Frame: 24 weeks
Core temperature (°C);
24 weeks
Systolic blood pressure predicting mortality in patients with acute secondary peritonitis at admission
Time Frame: 24 weeks
Systolic blood pressure (mmHg);
24 weeks
Hearth rate predicting mortality in patients with acute secondary peritonitis at admission
Time Frame: 24 weeks
Hearth rate (bpm);
24 weeks
Responsiveness predicting mortality in patients with acute secondary peritonitis at admission
Time Frame: 24 weeks
Alert/verbal/painful/unresponsive (AVPU) responsiveness scale;
24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2018

Primary Completion (Actual)

May 1, 2018

Study Completion (Actual)

May 31, 2018

Study Registration Dates

First Submitted

January 5, 2018

First Submitted That Met QC Criteria

January 17, 2018

First Posted (Actual)

January 24, 2018

Study Record Updates

Last Update Posted (Actual)

September 18, 2018

Last Update Submitted That Met QC Criteria

September 17, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Sepsis

Clinical Trials on Management

3
Subscribe